Top compounds associated with response to LILRA2


Feature Type Standardized
Nominal ANOVA
mRNA momelotinib CTRPv2 pan-cancer AAC 0.072 0.04
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.071 0.04
mRNA L-685458 CTRPv2 pan-cancer AAC -0.078 0.04
mRNA Axitinib CTRPv2 pan-cancer AAC 0.071 0.04
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.07 0.04
mRNA temsirolimus CTRPv2 pan-cancer AAC -0.1 0.04
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.07 0.05
mRNA NVP-ADW742 CTRPv2 pan-cancer AAC 0.072 0.05
mRNA AZ-3146 CTRPv2 pan-cancer AAC 0.071 0.05
mRNA Ki8751 CTRPv2 pan-cancer AAC 0.073 0.05
Download CSV